Tau uncovered: Alzheimer’s diagnosis and treatment

Tau is a key target for biomarkers and disease-modifying therapies

AbbVie reveals positive results from Phase 3 EPCORE DLBCL-4 trial

Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Minimising invisible risks in cancer and immunology research

Endotoxin, a lipopolysaccharide (LPS) originating from the outer membrane of Gram-negative bacteria, remains one of the most prevalent and challenging contaminants in recombinant protein preparations

Collaboration to advance tumour-selective antibody therapies for cancer

Combotope Therapeutics has formed a strategic research collaboration with Boehringer Ingelheim.

News

Subscribe to our Newsletter

© 2026 Setform Limited.